Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Rheumatoid Arthritis; Rheumatoid Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06880653
What this trial is testing

Dose Response of Exercise for Arthritis Management

Who this might be right for
ArthritisRheumatoid Arthritis (RA)Gout+3 more
University of South Carolina 285
Post-approval studies (Phase 4)Study completedNCT00356473
What this trial is testing

Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
University of California, Los Angeles 20
Large-scale testing (Phase 3)Study completedNCT02019472
What this trial is testing

A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 559
Large-scale testing (Phase 3)Study completedNCT00160602
What this trial is testing

Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 590
Not applicableStudy completedNCT04674085
What this trial is testing

Real-life Experience of Tofacitinib in Patients With Treatment-Resistant Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisTreatment Adherence and Compliance
Umraniye Education and Research Hospital 35
Not applicableStudy completedNCT04948775
What this trial is testing

Cervical Stabilization Exercises in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Izmir Katip Celebi University 26
Testing effectiveness (Phase 2)Study completedNCT00626275
What this trial is testing

Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 46
Post-approval studies (Phase 4)Study completedNCT00504777
What this trial is testing

MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 36
Testing effectiveness (Phase 2)Study completedNCT00411424
What this trial is testing

Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 54
Not applicableStudy completedNCT01656278
What this trial is testing

An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis

Who this might be right for
ArthritisArthritis, RheumatoidJoint Diseases+4 more
Professor of Rheumatology, MD, DMSci, Kim Horslev-Petersen 200
Testing effectiveness (Phase 2)Study completedNCT05957107
What this trial is testing

Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Beijing VDJBio Co., LTD. 181
Testing effectiveness (Phase 2)Study completedNCT02065700
What this trial is testing

Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 739
Not applicableActive Not RecruitingNCT04871919
What this trial is testing

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Alfasigma S.p.A. 1,304
Not applicableStudy completedNCT02982083
What this trial is testing

Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sara Saeidi Shahri 34
Testing effectiveness (Phase 2)Study completedNCT00545454
What this trial is testing

Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sanofi 79
Large-scale testing (Phase 3)Study completedNCT00264537
What this trial is testing

The Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive

Who this might be right for
Rheumatoid Arthritis
Centocor, Inc. 637
Not applicableUnknownNCT05114343
What this trial is testing

Effectiveness and Feasibility of a Home-based Exercise Program for Adolescents With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic ArthritisJuvenile ArthritisJuvenile Rheumatoid Arthritis
University of Sao Paulo General Hospital 30
Large-scale testing (Phase 3)Study completedNCT01604343
What this trial is testing

CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 1,670
Testing effectiveness (Phase 2)Looking for participantsNCT07423533
What this trial is testing

Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD

Who this might be right for
Rheumatoid Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 450
Testing effectiveness (Phase 2)Study completedNCT06028438
What this trial is testing

Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 103
Next Page